Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
626208-62-6
953409-00-2
1787375-26-1
321432-05-7 | 4-[(4-Fluorobenzyl)oxy]-3-methoxybenzenecarbaldehyde | AA00BZ6D | MFCD00202628
338982-12-0 | 3-(2-Chlorophenyl)-5-isoxazolecarboxylic acid | AA00BZBR | MFCD01935954
400750-29-0 | Methyl 4-(1h-pyrazol-1-yl)benzoate | AA00BZGE | MFCD01821225
42406-52-0 | N-Alpha-phthalyl-l-asparagine | AA00BZMS | MFCD00190991
328261-31-0 | 1-(Benzo[d][1,3]dioxol-5-yl)-N-(pyridin-3-ylmethyl)methanamine | AA00BZSM | MFCD01135341
331443-96-0 | 4-Chloro-8-fluoro-5h-pyrimido[5,4-b]indole | AA00BZYY | MFCD00753478
352534-81-7 | 3-Butoxyphenylboronic acid | AA00C06W | MFCD03427053
40000-79-1 | 3,4-Dihydro-1h-[1,8]naphthyridin-2-one | AA00C0CO | MFCD05664026
356534-53-7 | 1-(T-Butyloxycarbonyl)-2-triphenylphosphoniumhydrazine bromide | AA00C0IG | MFCD04973132
42267-27-6 | (S)-N-(4-(2,5-Dioxooxazolidin-4-yl)butyl)-2,2,2-trifluoroacetamide | AA00C0PO | MFCD11046652
Journal: Bioorganic & medicinal chemistry letters20101101